[ACRX] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
16-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- -5.51%
YoY- 6.73%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 252 507 570 442 2 1,862 443 -31.27%
PBT -7,485 -6,739 70,666 -8,674 -7,917 -8,375 -9,846 -16.66%
Tax -1 11 3 -321 467 796 5 -
NP -7,484 -6,750 70,663 -8,353 -7,917 -8,375 -9,851 -16.69%
Tax Rate - - -0.00% - - - - -
Total Cost 7,736 7,257 -70,093 8,795 7,919 10,237 10,294 -17.29%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -2,969.84 -1,331.36 12,397.02 -1,889.82 -395,850.00 -449.79 -2,223.70 21.21%
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -1.01 -0.91 9.60 -1.15 -1.24 -1.40 -1.65 -27.84%
EPS Diluted -1.01 -0.91 9.60 -1.15 -1.24 -1.40 -1.65 -27.84%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.